Fenofibrate use while Breastfeeding
Drugs containing Fenofibrate: TriCor, Antara, Lipofen, Lofibra, Triglide, Fenoglide, Lipidil EZ, Lipidil Supra, Lipidil Micro
Fenofibrate Levels and Effects while Breastfeeding
Summary of Use during Lactation
No relevant published information exists on the use of fenofibrate during breastfeeding. An alternate drug is preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Possible Effects on Lactation
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Cholestyramine, Colesevelam, Colestipol
References
Fenofibrate Identification
Substance Name
CAS Registry Number
49562-28-9
Drug Class
- Anticholesteremic Agents
- Antilipemic Agents
Administrative Information
LactMed Record Number
737
Information from the National Library of Medicine's LactMed Database.
Last Revision Date
2009-09-29
Disclaimer
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
See Also...
- Fenofibrate use during Pregnancy
- Fenofibrate Consumer Information
- Breastfeeding Support Group
- Safe Medications during Breastfeeding
- Medicine use while Breastfeeding
- Medicine use during Pregnancy
Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.
